Address
Email address
Phone number
https://abbott.comAbbott | Life-Changing Health Care TechnologiesInnovative medical devices and health care solutions for cardiovascular health, diabetes management, diagnostic testing, nutrition, chronic pain and more.
Name
Abbott Medical Estonia OÜ
Registry code
11992890
VAT number
EE101403218
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
15.09.2010 (14)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
46462 - Wholesale of medical appliances and surgical and orthopaedic instruments and devices
4 984 424 €
183 265 €
4%
6 829 €
(estimate is approximate)
2 050 043 €
4
Submitted
No tax arrears
9%
6%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Kristin Reinaas 10.04.1979 (45) | - | Procurator | - |
| 2019 10.06.2020 | 2020 29.07.2021 | 2021 14.07.2022 | 2022 22.06.2023 | 2023 25.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 5 120 698 € | 5 009 684 € | 5 738 499 € | 6 718 946 € | 4 984 424 € |
| Net profit (loss) for the period | 154 378 € | 88 545 € | 257 785 € | 187 311 € | 183 265 € |
| Profit Margin | 3% | 2% | 4% | 3% | 4% |
| Current Assets | 2 191 850 € | 2 066 118 € | 2 883 678 € | 2 647 972 € | 2 929 894 € |
| Fixed Assets | 2 002 € | 260 556 € | 516 € | 0 € | 74 106 € |
| Total Assets | 2 193 852 € | 2 326 674 € | 2 884 194 € | 2 647 972 € | 3 004 000 € |
| Current Liabilities | 842 578 € | 904 991 € | 1 204 726 € | 781 193 € | 953 957 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 1 351 274 € | 1 421 683 € | 1 679 468 € | 1 866 779 € | 2 050 043 € |
| Employees | 3 | 3 | 3 | 4 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 3 153 718.21 € | 296 626.27 € | 56 052.92 € | 4 |
| 2023 Q4 | 2 351 238.5 € | 226 738.48 € | 48 017.63 € | 4 |
| 2023 Q3 | 1 795 897.66 € | 199 113.53 € | 46 167.77 € | 5 |
| 2023 Q2 | 2 765 016.47 € | 200 996.94 € | 40 284.52 € | 4 |
| 2023 Q1 | 2 832 145.65 € | 217 434.2 € | 40 977.04 € | 4 |
| 2022 Q4 | 4 160 509.9 € | 227 220.14 € | 36 079 € | 4 |
| 2022 Q3 | 2 591 759.77 € | 196 381.84 € | 25 681.5 € | 4 |
| 2022 Q2 | 2 804 153.97 € | 251 009.26 € | 26 233.59 € | 3 |
| 2022 Q1 | 2 991 089.28 € | 218 846.84 € | 29 692.46 € | 3 |
| 2021 Q4 | 2 833 241.4 € | 227 531.75 € | 23 114.41 € | 3 |
| 2021 Q3 | 2 197 574.47 € | 160 732.38 € | 24 045.97 € | 3 |
| 2021 Q2 | 2 943 088.22 € | 229 314.42 € | 23 155.42 € | 3 |
| 2021 Q1 | 2 722 270.16 € | 188 408.47 € | 33 097.64 € | 3 |
| 2020 Q4 | 2 738 271.22 € | 199 599.05 € | 27 215.36 € | 3 |
| 2020 Q3 | 1 982 227.45 € | 161 554.15 € | 26 089.21 € | 3 |
| 2020 Q2 | 2 023 231.23 € | 151 966.65 € | 23 098.84 € | 3 |
| 2020 Q1 | 2 367 623.25 € | 183 579.36 € | 34 747.72 € | 3 |
